Literature DB >> 7730351

Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase.

J P Jost1, M Siegmann, L Sun, R Leung.   

Abstract

We have previously shown that in developing chicken embryos and differentiating mouse myoblasts, the demethylation of 5-metCpGs occurs through the replacement of 5-methylcytosine by cytosine (Jost, J. P. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 4685-4688; Jost, J. P. & Jost, Y.C. (1994) J. Biol. Chem. 269, 10040-10043). We have now purified over 30,000-fold a 5-methylcytosine-DNA glycosylase from 12-day-old chicken embryos. The enzyme copurifies with a mismatch-specific thymine-DNA glycosylase and an apyrimidic-endonuclease. The reaction product of the highly purified 5-methylcytosine-DNA glycosylase is 5-methylcytosine. The copurified apyrimidic-endonuclease activity cleaves 3' from the apyrimidic sugar. A 52.5-kDa peptide, isolated as a single band from preparative SDS-polyacrylamide gels, has both the 5-methylcytosine-DNA glycosylase and the mismatch-specific thymine-DNA glycosylase activities. 5-Methylcytosine-DNA glycosylase has an apparent pI of 5.5-7.5 and maximal activity between pH 6.5 and 7.5. The Km for hemimethylated oligonucleotide substrate is 8 x 10(-8) M with a Vmax of 4 x 10(-11) mol/h/micrograms proteins. 5-Methylcytosine-DNA glycosylase binds equally well to methylated and non-methylated DNA. The enzyme reacts six times faster with the hemimethylated DNA than with the same bifilarly methylated DNA sequence, and single-stranded methylated DNA is not a substrate. The action of the enzyme is distributive.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730351     DOI: 10.1074/jbc.270.17.9734

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene.

Authors:  B Zhu; D Benjamin; Y Zheng; H Angliker; S Thiry; M Siegmann; J P Jost
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  5-Methylcytosine DNA glycosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation.

Authors:  J P Jost; E J Oakeley; B Zhu; D Benjamin; S Thiry; M Siegmann; Y C Jost
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

Review 3.  The marks, mechanisms and memory of epigenetic states in mammals.

Authors:  V K Rakyan; J Preis; H D Morgan; E Whitelaw
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

Review 4.  DNA demethylation.

Authors:  A P Wolffe; P L Jones; P A Wade
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Inducible DNA demethylation mediated by the maize Suppressor-mutator transposon-encoded TnpA protein.

Authors:  Hongchang Cui; Nina V Fedoroff
Journal:  Plant Cell       Date:  2002-11       Impact factor: 11.277

Review 6.  DNA glycosylases in the base excision repair of DNA.

Authors:  H E Krokan; R Standal; G Slupphaug
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

7.  DEMETER and REPRESSOR OF SILENCING 1 encode 5-methylcytosine DNA glycosylases.

Authors:  Teresa Morales-Ruiz; Ana Pilar Ortega-Galisteo; María Isabel Ponferrada-Marín; María Isabel Martínez-Macías; Rafael R Ariza; Teresa Roldán-Arjona
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-19       Impact factor: 11.205

8.  Evidence that protein binding specifies sites of DNA demethylation.

Authors:  C L Hsieh
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA.

Authors:  K Matsuo; J Silke; O Georgiev; P Marti; N Giovannini; D Rungger
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

Review 10.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.